Pharmacy Regulatory Compliance
Retail, compounding, specialty, and mail-order pharmacies under DEA and state board jurisdiction.
4,686
Total Enforcement Actions
4,022
Actions This Year
—
Total Penalties Tracked
4,685
Critical / High Severity
Regulatory Overview
Pharmacies operate under a multi-layered regulatory framework: DEA registration governs controlled substance handling; FDA enforces compounding standards and drug quality; and state pharmacy boards license pharmacists, technicians, and facilities. Compounding pharmacies face heightened scrutiny under FDCA Section 503A and 503B following the 2012 meningitis outbreak, with FDA conducting facility inspections and 483 observations.
Primary Enforcement Focus
DEA diversion investigations, FDA compounding inspections, and state board license actions are the primary enforcement mechanisms. OIG exclusions affect individual pharmacists.
Common Violation Patterns
Controlled Substance Diversion
Dispensing without valid prescription, excessive dispensing of opioids, DEA record-keeping failures, and employee theft.
Compounding Violations
Sterility failures, beyond-use date violations, compounding copies of commercially available drugs, lack of PCAB accreditation.
PBM Audit Recoupment
Pharmacy benefit manager audits finding documentation errors, wrong days-supply, or early refills resulting in large recoupment demands.
HIPAA Breaches
Prescription pickup authorization failures, improper disposal of PHI, employee snooping on celebrity/VIP prescriptions.
Enforcement Actions — Pharmacy
Violations Signal Board
Latest Pharmacy NewsAll
Articles will appear here once the feed is seeded.
Key Regulations
21 CFR Parts 1301–1321 — DEA CSA
DEA registration, Schedule II ordering (Form 222), inventory records, theft/loss reporting, and dispensing limits.
FDCA 503A/503B — Compounding
503A for patient-specific compounding; 503B for outsourcing facilities. FDA can issue 483s, Warning Letters, and seize adulterated/misbranded drugs.
USP <797> — Sterile Compounding
Enforceable contamination control standards for sterile preparations. State boards regularly cite USP <797> violations in inspections.
HIPAA 45 CFR Parts 160 & 164
Pharmacy PHI obligations including prescription records, patient counseling, and breach notification requirements.
State Pharmacy Practice Acts
Each state board sets prescribing/dispensing limits, tech-to-pharmacist ratios, continuing education, and discipline procedures.
Official Resources
DEA Diversion Control Division
DEA registration portal, scheduling decisions, and diversion case database.
FDA Drug Recalls & Enforcement
Current drug recalls, market withdrawals, and FDA enforcement actions against pharmacies.
NABP CPE Monitor
National Association of Boards of Pharmacy — multistate licensure verification and discipline records.